Sherief Abd-Elsalam
Tanta, Egypt
Location status: Recruiting
NCT Number: NCT04499898
Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 2 / Phase 3
Tanta, Egypt
Location status: Recruiting
A Randomized controlled trial of carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Carvedilol
Other names: carvid
Endoscopic band ligation
Other names: band ligation
Time frame: 1 year
The number of patients with the first variceal bleeding within 1 year
Contact information is provided by the study sponsor or research team.
Nabila el-gazzar, ass. lect.
CONTACT
Sherief Abd-Elsalam, ass. prof.
CONTACT
Sherief Abd-Elsalam
Other
Randomized Controlled Trial of Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding in Cirrhotic Patients With Arterial Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07122622
Digestive System Diseases, Esophageal Diseases
Roma, Italia, Italy
View Trial DetailsNCT07163689
Digestive System Diseases, Esophageal Diseases
Amiens, Picardie, France
View Trial DetailsNCT06970509
Digestive System Diseases, Esophageal Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT06908798
Digestive System Diseases, Esophageal Diseases
Tanta, Gharbyea, Egypt
View Trial Details